NERAMEXANE Forest Laboratories Inc.(Brief Article)

Chemical Market Reporter, July, 2001

NERAMEXANE Forest Laboratories Inc. will develop and market neramexane, a patented novel NMDA receptor antagonist developed by Merz and Co. of Germany, in the US. NMDA receptors mediate a variety of neurological functions. Neramexane will enter into Phase II trials for a broad range of indications.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement